- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: imidapril
    drug_mesh: MESH:C065166
    drugbank: DB:DB11783
  links:
    - key: produces
      source: MESH:C065166
      target: MESH:C078006
    - key: decreases activity of
      source: MESH:C078006
      target: UniProt:P12821
    - key: positively regulates
      source: UniProt:P12821
      target: GO:0002003
    - key: positively regulates
      source: GO:0002003
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0032263
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:C065166
      label: Drug
      name: imidapril
    - id: MESH:C078006
      label: Drug
      name: imidaprilat
    - id: UniProt:P12821
      label: Protein
      name: Angiotensin-converting enzyme
    - id: GO:0002003
      label: BiologicalProcess
      name: angiotensin maturation
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference: https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL317094/ https://en.wikipedia.org/wiki/ACE_inhibitor#Effects
- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: azelnidipine
    drug_mesh: MESH:C061679
    drugbank: DB:DB09230
  links:
    - key: decreases activity of
      source: MESH:C061679
      target: UniProt:Q02641
    - key: positively regulates
      source: UniProt:Q02641
      target: GO:0061577
    - key: positively regulates
      source: GO:0061577
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0032263
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:C061679
      label: Drug
      name: azelnidipine
    - id: UniProt:Q02641
      label: Protein
      name: Voltage-dependent L-type calcium channel subunit beta-1
    - id: GO:0061577
      label: BiologicalProcess
      name: calcium ion transmembrane transport via high voltage-gated calcium channel
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference: https://go.drugbank.com/drugs/DB09230#mechanism-of-action
  comments: The drug may also modulate other members of the Voltage-gated L-type calcium channel protein family (https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1275868/) or T-type calcium channel protein family (https://en.wikipedia.org/wiki/Azelnidipine).
- directed: true
  graph:
    disease: Cystitis, Interstitial
    disease_mesh: MESH:D018856
    drug: dimethyl sulfoxide
    drug_mesh: MESH:D004121
    drugbank: DB:DB01093
  links:
    - key: negatively correlated with
      source: MESH:D004121
      target: GO:0006954
    - key: negatively correlated with
      source: MESH:D004121
      target: HP:0012531
    - key: positively correlated with
      source: GO:0006954
      target: HP:0100577
    - key: positively correlated with
      source: HP:0012531
      target: HP:0100577
    - key: manifestation of
      source: HP:0100577
      target: MESH:D018856
  multigraph: true
  nodes:
    - id: MESH:D004121
      label: Drug
      name: dimethyl sulfoxide
    - id: GO:0006954
      label: BiologicalProcess
      name: inflammatory response
    - id: HP:0012531
      label: PhenotypicFeature
      name: Pain
    - id: HP:0100577
      label: PhenotypicFeature
      name: Urinary bladder inflammation
    - id: MESH:D018856
      label: Disease
      name: Cystitis, Interstitial
  reference: https://go.drugbank.com/drugs/DB01093
  comments: The disease is denoted as Ulcerative cystitis in the original file as per DrugCentral.
- directed: true
  graph:
    disease: Migraine Disorders
    disease_mesh: MESH:D008881
    drug: naratriptan
    drug_mesh: MESH:C106783
    drugbank: DB:DB00952
  links:
    - key: positively regulates
      source: MESH:C106783
      target: UniProt:P28221
    - key: positively regulates
      source: MESH:C106783
      target: UniProt:P28222
    - key: positively regulates
      source: MESH:C106783
      target: UniProt:P30939
    - key: positively regulates
      source: UniProt:P28222
      target: GO:0042310
    - key: negatively regulates
      source: UniProt:P28221
      target: GO:0006954
    - key: negatively regulates
      source: UniProt:P30939
      target: GO:0006954
    - key: positively correlated with
      source: GO:0006954
      target: MESH:D008881
    - key: negatively correlated with
      source: GO:0042310
      target: MESH:D008881
  multigraph: true
  nodes:
    - id: MESH:C106783
      label: Drug
      name: naratriptan
    - id: UniProt:P28221
      label: Protein
      name: 5-hydroxytryptamine receptor 1D
    - id: UniProt:P28222
      label: Protein
      name: 5-hydroxytryptamine receptor 1B
    - id: UniProt:P30939
      label: Protein
      name: 5-hydroxytryptamine receptor 1F
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: GO:0006954
      label: BiologicalProcess
      name: inflammatory response
    - id: MESH:D008881
      label: Disease
      name: Migraine Disorders
  reference: https://go.drugbank.com/drugs/DB00952#mechanism-of-action https://pubmed.ncbi.nlm.nih.gov/15320857/
  comments: The disease is denoted as Migraine in the original file.
- directed: true
  graph:
    disease: Anxiety
    disease_mesh: MESH:D001007
    drug: halazepam
    drug_mesh: MESH:C010175
    drugbank: DB:DB00801
  links:
    - key: positively regulates
      source: MESH:C010175
      target: MESH:D018079
    - key: positively regulates
      source: MESH:D018079
      target: GO:0006821
    - key: positively correlated with
      source: GO:0006821
      target: GO:0060081
    - key: negatively correlated with
      source: GO:0060081
      target: MESH:D000071080
    - key: positively correlated with
      source: MESH:D000071080
      target: MESH:D001007
  multigraph: true
  nodes:
    - id: MESH:C010175
      label: Drug
      name: halazepam
    - id: MESH:D018079
      label: GeneFamily
      name: Receptors, GABA
    - id: GO:0006821
      label: BiologicalProcess
      name: chloride transport
    - id: GO:0060081
      label: BiologicalProcess
      name: membrane hyperpolarization
    - id: MESH:D000071080
      label: BiologicalProcess
      name: Cortical Excitability
    - id: MESH:D001007
      label: Disease
      name: Anxiety
  reference: https://go.drugbank.com/drugs/DB00801 https://pubchem.ncbi.nlm.nih.gov/compound/31640#section=Pharmacology-and-Biochemistry
- directed: true
  graph:
    disease: Anxiety
    disease_mesh: MESH:D001007
    drug: midazolam
    drug_mesh: MESH:D008874
    drugbank: DB:DB00683
  links:
    - key: positively regulates
      source: MESH:D008874
      target: MESH:D018079
    - key: positively regulates
      source: MESH:D018079
      target: GO:0006821
    - key: positively correlated with
      source: GO:0006821
      target: GO:0060081
    - key: negatively correlated with
      source: GO:0060081
      target: MESH:D000071080
    - key: positively correlated with
      source: MESH:D000071080
      target: MESH:D001007
  multigraph: true
  nodes:
    - id: MESH:D008874
      label: Drug
      name: midazolam
    - id: MESH:D018079
      label: GeneFamily
      name: Receptors, GABA
    - id: GO:0006821
      label: BiologicalProcess
      name: chloride transport
    - id: GO:0060081
      label: BiologicalProcess
      name: membrane hyperpolarization
    - id: MESH:D000071080
      label: BiologicalProcess
      name: Cortical Excitability
    - id: MESH:D001007
      label: Disease
      name: Anxiety
  reference: https://go.drugbank.com/drugs/DB00683
- directed: true
  graph:
    disease: Candidiasis, Cutaneous
    disease_mesh: MESH:D002179
    drug: nystatin
    drug_mesh: MESH:D009761
    drugbank: DB:DB00646
  links:
    - key: causes
      source: MESH:D009761
      target: MESH:D015227
    - key: disrupts
      source: MESH:D015227
      target: GO:0006811
    - key: located in
      source: GO:0006811
      target: GO:0030445
    - key: produces
      source: MESH:D009761
      target: UBERON:0008915
    - key: located in
      source: UBERON:0008915
      target: GO:0030445
    - key: molecularly interacts with
      source: MESH:D009761
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D002179
  multigraph: true
  nodes:
    - id: MESH:D009761
      label: Drug
      name: nystatin
    - id: UBERON:0008915
      label: GrossAnatomicalStructure
      name: pore
    - id: MESH:D015227
      label: BiologicalProcess
      name: Lipid Peroxidation
    - id: GO:0006811
      label: BiologicalProcess
      name: ion transport
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D002179
      label: Disease
      name: Candidiasis, Cutaneous
  reference: https://go.drugbank.com/drugs/DB00646 https://en.wikipedia.org/wiki/Nystatin#Mechanism_of_action
  comments: MESH:D002179 was denoted as Candidiasis of skin in the original file.
- directed: true
  graph:
    disease: Candidiasis, Oral
    disease_mesh: MESH:D002180
    drug: nystatin
    drug_mesh: MESH:D009761
    drugbank: DB:DB00646
  links:
    - key: causes
      source: MESH:D009761
      target: MESH:D015227
    - key: disrupts
      source: MESH:D015227
      target: GO:0006811
    - key: located in
      source: GO:0006811
      target: GO:0030445
    - key: produces
      source: MESH:D009761
      target: UBERON:0008915
    - key: located in
      source: UBERON:0008915
      target: GO:0030445
    - key: molecularly interacts with
      source: MESH:D009761
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D002180
  multigraph: true
  nodes:
    - id: MESH:D009761
      label: Drug
      name: nystatin
    - id: UBERON:0008915
      label: GrossAnatomicalStructure
      name: pore
    - id: MESH:D015227
      label: BiologicalProcess
      name: Lipid Peroxidation
    - id: GO:0006811
      label: BiologicalProcess
      name: ion transport
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D002180
      label: Disease
      name: Candidiasis, Oral
  reference: https://go.drugbank.com/drugs/DB00646 https://en.wikipedia.org/wiki/Nystatin#Mechanism_of_action
  comments: MESH:D002179 was denoted as Candidiasis of mouth in the original file.
- directed: true
  graph:
    disease: Candidiasis, Vulvovaginal
    disease_mesh: MESH:D002181
    drug: nystatin
    drug_mesh: MESH:D009761
    drugbank: DB:DB00646
  links:
    - key: causes
      source: MESH:D009761
      target: MESH:D015227
    - key: disrupts
      source: MESH:D015227
      target: GO:0006811
    - key: located in
      source: GO:0006811
      target: GO:0030445
    - key: produces
      source: MESH:D009761
      target: UBERON:0008915
    - key: located in
      source: UBERON:0008915
      target: GO:0030445
    - key: molecularly interacts with
      source: MESH:D009761
      target: CHEBI:16933
    - key: part of
      source: CHEBI:16933
      target: GO:0030445
    - key: regulates
      source: GO:0030445
      target: MESH:D002463
    - key: in taxon
      source: MESH:D002463
      target: NCBITaxon:237561
    - key: causes
      source: NCBITaxon:237561
      target: MESH:D002181
  multigraph: true
  nodes:
    - id: MESH:D009761
      label: Drug
      name: nystatin
    - id: UBERON:0008915
      label: GrossAnatomicalStructure
      name: pore
    - id: MESH:D015227
      label: BiologicalProcess
      name: Lipid Peroxidation
    - id: GO:0006811
      label: BiologicalProcess
      name: ion transport
    - id: CHEBI:16933
      label: ChemicalSubstance
      name: ergosterol
    - id: GO:0030445
      label: CellularComponent
      name: yeast-form cell wall
    - id: MESH:D002463
      label: PhenotypicFeature
      name: Cell Membrane Permeability
    - id: NCBITaxon:237561
      label: OrganismTaxon
      name: Candida albicans SC5314
    - id: MESH:D002181
      label: Disease
      name: Candidiasis, Vulvovaginal
  reference: https://go.drugbank.com/drugs/DB00646 https://en.wikipedia.org/wiki/Nystatin#Mechanism_of_action
  comments: MESH:D002179 was denoted as Candidiasis of mouth in the original file.
- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: bisoprolol
    drug_mesh: MESH:D017298
    drugbank: DB:DB00612
  links:
    - key: decreases activity of
      source: MESH:D017298
      target: UBERON:0034729
    - key: positively correlated with
      source: UBERON:0034729
      target: GO:0042310
    - key: decreases activity of
      source: MESH:D017298
      target: UniProt:P08588
    - key: positively correlated with
      source: UniProt:P08588
      target: HP:0033533
    - key: positively correlated with
      source: HP:0033533
      target: HP:0032263
    - key: negatively correlated with
      source: MESH:D017298
      target: GO:0002001
    - key: positively correlated with
      source: GO:0002001
      target: GO:0042310
    - key: positively correlated with
      source: GO:0042310
      target: HP:0032263
    - key: positively correlated with
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D017298
      label: Drug
      name: bisoprolol
    - id: UniProt:P08588
      label: Protein
      name: Beta-1 adrenergic receptor
    - id: UBERON:0034729
      label: GrossAnatomicalStructure
      name: sympathetic nerve
    - id: GO:0002001
      label: BiologicalProcess
      name: renin secretion into blood stream
    - id: GO:0042310
      label: BiologicalProcess
      name: vasoconstriction
    - id: HP:0033533
      label: PhenotypicFeature
      name: Increased cardiac output
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference: https://go.drugbank.com/drugs/DB00612 https://en.wikipedia.org/wiki/Bisoprolol#Mechanism_of_action
  comments: At higher doses, bisoprolol antagonizes the B2 receptors, but is mainly selective for B1 receptors.
- directed: true
  graph:
    disease: Hyperlipidemias
    disease_mesh: MESH:D006949
    drug: dextrothyroxine
    drug_mesh: MESH:D003918
    drugbank: DB:DB00509
  links:
    - key: increases activity of
      source: MESH:D003918
      target: UniProt:P10827
    - key: increases activity of
      source: MESH:D003918
      target: UniProt:P10828
    - key: positively correlated with
      source: UniProt:P10827
      target: GO:0006707
    - key: increases activity of
      source: UniProt:P10828
      target: UniProt:P01130
    - key: positively correlated with
      source: UniProt:P01130
      target: GO:0043691
    - key: positively correlated with
      source: UniProt:P01130
      target: GO:0034381
    - key: negatively correlated with
      source: GO:0006707
      target: MESH:D006949
    - key: negatively correlated with
      source: GO:0043691
      target: MESH:D006949
    - key: negatively correlated with
      source: GO:0034381
      target: MESH:D006949
  multigraph: true
  nodes:
    - id: MESH:D003918
      label: Drug
      name: dextrothyroxine
    - id: UniProt:P10827
      label: Protein
      name: Thyroid hormone receptor alpha
    - id: UniProt:P10828
      label: Protein
      name: Thyroid hormone receptor beta
    - id: GO:0006707
      label: BiologicalProcess
      name: cholesterol catabolic process
    - id: UniProt:P01130
      label: Protein
      name: Low-density lipoprotein receptor
    - id: GO:0043691
      label: BiologicalProcess
      name: reverse cholesterol transport
    - id: GO:0034381
      label: BiologicalProcess
      name: plasma lipoprotein particle clearance
    - id: MESH:D006949
      label: Disease
      name: Hyperlipidemias
  reference: https://pubmed.ncbi.nlm.nih.gov/9440092/ https://pubmed.ncbi.nlm.nih.gov/20935564/ https://go.drugbank.com/drugs/DB00509#mechanism-of-action https://en.wikipedia.org/wiki/Triiodothyronine#Lipids
- directed: true
  graph:
    disease: Ocular hypertension
    disease_mesh: MESH:D009798
    drug: betaxolol
    drug_mesh: MESH:D015784
    drugbank: DB:DB00195
  links:
    - key: decreases activity of
      source: MESH:D015784
      target: UniProt:P08588
    - key: participates in
      source: UniProt:P08588
      target: REACT:R-HSA-418555
    - key: increases abundance of
      source: REACT:R-HSA-418555
      target: CHEBI:17489
    - key: positively correlated with
      source: CHEBI:17489
      target: UBERON:0001796
    - key: positively correlated with
      source: UBERON:0001796
      target: MESH:D009798
  multigraph: true
  nodes:
    - id: MESH:D015784
      label: Drug
      name: betaxolol
    - id: UniProt:P08588
      label: Protein
      name: Beta-1 adrenergic receptor
    - id: REACT:R-HSA-418555
      label: Pathway
      name: G alpha (s) signalling events
    - id: CHEBI:17489
      label: ChemicalSubstance
      name: 3,5-cyclic AMP
    - id: UBERON:0001796
      label: GrossAnatomicalStructure
      name: aqueous humor of eyeball
    - id: MESH:D009798
      label: Disease
      name: Ocular Hypertension
  reference: https://go.drugbank.com/drugs/DB00195#mechanism-of-action https://en.wikipedia.org/wiki/Betaxolol https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL423/ https://pubchem.ncbi.nlm.nih.gov/compound/2369#section=Pharmacology-and-Biochemistry
- directed: true
  graph:
    disease: Open-angle glaucoma
    disease_mesh: MESH:D005902
    drug: betaxolol
    drug_mesh: MESH:D015784
    drugbank: DB:DB00195
  links:
    - key: decreases activity of
      source: MESH:D015784
      target: UniProt:P08588
    - key: participates in
      source: UniProt:P08588
      target: REACT:R-HSA-418555
    - key: increases abundance of
      source: REACT:R-HSA-418555
      target: CHEBI:17489
    - key: positively correlated with
      source: CHEBI:17489
      target: UBERON:0001796
    - key: positively correlated with
      source: UBERON:0001796
      target: HP:0007906
    - key: positively correlated with
      source: HP:0007906
      target: MESH:D005902
  multigraph: true
  nodes:
    - id: MESH:D015784
      label: Drug
      name: betaxolol
    - id: UniProt:P08588
      label: Protein
      name: Beta-1 adrenergic receptor
    - id: REACT:R-HSA-418555
      label: Pathway
      name: G alpha (s) signalling events
    - id: CHEBI:17489
      label: ChemicalSubstance
      name: 3,5-cyclic AMP
    - id: UBERON:0001796
      label: GrossAnatomicalStructure
      name: aqueous humor of eyeball
    - id: HP:0007906
      label: PhenotypicFeature
      name: Ocular Hypertension
    - id: MESH:D005902
      label: Disease
      name: Open-angle glaucoma
  reference: https://go.drugbank.com/drugs/DB00195#mechanism-of-action https://en.wikipedia.org/wiki/Betaxolol https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL423/ https://pubchem.ncbi.nlm.nih.gov/compound/2369#section=Pharmacology-and-Biochemistry
- directed: true
  graph:
    disease: Abdominal abscess
    disease_mesh: MESH:D018784
    drug: ertapenem
    drug_mesh: MESH:C446479
    drugbank: DB:DB00303
  links:
    - key: negatively regulates
      source: MESH:C446479
      target: Pfam:PF00905
    - key: positively regulates
      source: Pfam:PF00905
      target: GO:0009252
    - key: in taxon
      source: GO:0009252
      target: NCBITaxon:562
    - key: causes
      source: NCBITaxon:562
      target: MESH:D018784
  multigraph: true
  nodes:
    - id: MESH:C446479
      label: Drug
      name: ertapenem
    - id: Pfam:PF00905
      label: GeneFamily
      name: Penicillin binding proteins
    - id: GO:0009252
      label: BiologicalProcess
      name: peptidoglycan biosynthetic process
    - id: NCBITaxon:562
      label: OrganismTaxon
      name: Escherichia coli
    - id: MESH:D018784
      label: Disease
      name: Abdominal abscess
  reference: https://en.wikipedia.org/wiki/Ertapenem#Mechanism_of_action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1359/
- directed: true
  graph:
    disease: Pneumococcal pneumonia
    disease_mesh: MESH:D011018
    drug: ertapenem
    drug_mesh: MESH:C446479
    drugbank: DB:DB00303
  links:
    - key: negatively regulates
      source: MESH:C446479
      target: Pfam:PF00905
    - key: positively regulates
      source: Pfam:PF00905
      target: GO:0009252
    - key: in taxon
      source: GO:0009252
      target: NCBITaxon:1313
    - key: causes
      source: NCBITaxon:1313
      target: MESH:D011018
  multigraph: true
  nodes:
    - id: MESH:C446479
      label: Drug
      name: ertapenem
    - id: Pfam:PF00905
      label: GeneFamily
      name: Penicillin binding proteins
    - id: GO:0009252
      label: BiologicalProcess
      name: peptidoglycan biosynthetic process
    - id: NCBITaxon:1313
      label: OrganismTaxon
      name: Streptococcus pneumoniae
    - id: MESH:D011018
      label: Disease
      name: Pneumococcal pneumonia
  reference: https://en.wikipedia.org/wiki/Ertapenem#Mechanism_of_action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1359/
- directed: true
  graph:
    disease: Infectious disease of abdomen
    disease_mesh: MESH:D059413
    drug: ertapenem
    drug_mesh: MESH:C446479
    drugbank: DB:DB00303
  links:
    - key: negatively regulates
      source: MESH:C446479
      target: Pfam:PF00905
    - key: positively regulates
      source: Pfam:PF00905
      target: GO:0009252
    - key: in taxon
      source: GO:0009252
      target: NCBITaxon:562
    - key: in taxon
      source: GO:0009252
      target: NCBITaxon:573
    - key: in taxon
      source: GO:0009252
      target: NCBITaxon:550
    - key: in taxon
      source: GO:0009252
      target: NCBITaxon:287
    - key: causes
      source: NCBITaxon:573
      target: MESH:D059413
    - key: causes
      source: NCBITaxon:550
      target: MESH:D059413
    - key: causes
      source: NCBITaxon:287
      target: MESH:D059413
    - key: causes
      source: NCBITaxon:562
      target: MESH:D059413
  multigraph: true
  nodes:
    - id: MESH:C446479
      label: Drug
      name: ertapenem
    - id: Pfam:PF00905
      label: GeneFamily
      name: Penicillin binding proteins
    - id: GO:0009252
      label: BiologicalProcess
      name: peptidoglycan biosynthetic process
    - id: NCBITaxon:562
      label: OrganismTaxon
      name: Escherichia coli
    - id: NCBITaxon:573
      label: OrganismTaxon
      name: Klebsiella pneumoniae
    - id: NCBITaxon:550
      label: OrganismTaxon
      name: Enterobacter cloacae
    - id: NCBITaxon:287
      label: OrganismTaxon
      name: Pseudomonas aeruginosa
    - id: MESH:D059413
      label: Disease
      name: Infectious disease of abdomen
  reference: https://en.wikipedia.org/wiki/Ertapenem#Mechanism_of_action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1359/
- directed: true
  graph:
    disease: Bacterial pneumonia
    disease_mesh: MESH:D018410
    drug: ertapenem
    drug_mesh: MESH:C446479
    drugbank: DB:DB00303
  links:
    - key: negatively regulates
      source: MESH:C446479
      target: Pfam:PF00905
    - key: positively regulates
      source: Pfam:PF00905
      target: GO:0009252
    - key: in taxon
      source: GO:0009252
      target: NCBITaxon:562
    - key: causes
      source: NCBITaxon:562
      target: MESH:D018410
  multigraph: true
  nodes:
    - id: MESH:C446479
      label: Drug
      name: ertapenem
    - id: Pfam:PF00905
      label: GeneFamily
      name: Penicillin binding proteins
    - id: GO:0009252
      label: BiologicalProcess
      name: peptidoglycan biosynthetic process
    - id: NCBITaxon:562
      label: OrganismTaxon
      name: Escherichia coli
    - id: MESH:D018410
      label: Disease
      name: Bacterial pneumonia
  reference: https://en.wikipedia.org/wiki/Ertapenem#Mechanism_of_action https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1359/
- directed: true
  graph:
    disease: Hypertensive disorder
    disease_mesh: MESH:D006973
    drug: betaxolol
    drug_mesh: MESH:D015784
    drugbank: DB:DB00195
  links:
    - key: decreases activity of
      source: MESH:D015784
      target: UniProt:P08588
    - key: participates in
      source: UniProt:P08588
      target: REACT:R-HSA-418555
    - key: increases abundance of
      source: REACT:R-HSA-418555
      target: CHEBI:17489
    - key: positively regulates
      source: REACT:R-HSA-418555
      target: MESH:D020746
    - key: positively correlated with
      source: MESH:D020746
      target: GO:0060047
    - key: positively correlated with
      source: MESH:D020746
      target: MESH:D006339
    - key: positively correlated with
      source: GO:0060047
      target: HP:0032263
    - key: positively correlated with
      source: MESH:D006339
      target: HP:0032263
    - key: positively correlated with
      source: CHEBI:17489
      target: GO:0060047
    - key: manifestation of
      source: HP:0032263
      target: MESH:D006973
  multigraph: true
  nodes:
    - id: MESH:D015784
      label: Drug
      name: betaxolol
    - id: UniProt:P08588
      label: Protein
      name: Beta-1 adrenergic receptor
    - id: REACT:R-HSA-418555
      label: Pathway
      name: G alpha (s) signalling events
    - id: MESH:D020746
      label: GeneFamily
      name: Calcium Channels, L-Type
    - id: CHEBI:17489
      label: ChemicalSubstance
      name: 3,5-cyclic AMP
    - id: MESH:D006339
      label: BiologicalProcess
      name: Heart Rate
    - id: GO:0060047
      label: BiologicalProcess
      name: heart contraction
    - id: HP:0032263
      label: PhenotypicFeature
      name: Increased blood pressure
    - id: MESH:D006973
      label: Disease
      name: Hypertensive disorder
  reference: https://go.drugbank.com/drugs/DB00195#mechanism-of-action https://en.wikipedia.org/wiki/Betaxolol https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL423/ https://pubchem.ncbi.nlm.nih.gov/compound/2369#section=Pharmacology-and-Biochemistry https://en.wikipedia.org/wiki/CAMP-dependent_pathway#Importance
  comments: L-type calcium channels are modulated by the adrenergic nervous system, hence betaxolol could indirectly modulate L calcium channels, decreasing heart rate and contraction, ultimately decreasing high blood pressure (https://en.wikipedia.org/wiki/L-type_calcium_channel#Inhibition_and_modulation).
- directed: true
  graph:
    disease: Keratitis, Herpetic
    disease_mesh: MESH:D016849
    drug: vidarabine
    drug_mesh: MESH:D014740
    drugbank: DB:DB00194
  links:
    - key: produces
      source: MESH:D014740
      target: MESH:D001084
    - key: decreases activity of
      source: MESH:D001084
      target: UniProt:P04293
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0039686
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0090503
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0043631
    - key: in taxon
      source: GO:0043631
      target: NCBITaxon:10299
    - key: in taxon
      source: GO:0039686
      target: NCBITaxon:10299
    - key: in taxon
      source: GO:0090503
      target: NCBITaxon:10299
    - key: causes
      source: NCBITaxon:10299
      target: MESH:D016849
  multigraph: true
  nodes:
    - id: MESH:D014740
      label: Drug
      name: vidarabine
    - id: MESH:D001084
      label: ChemicalSubstance
      name: Vidarabine Phosphate
    - id: UniProt:P04293
      label: Protein
      name: DNA polymerase catalytic subunit
    - id: GO:0039686
      label: BiologicalProcess
      name: bidirectional double-stranded viral DNA replication
    - id: GO:0090503
      label: BiologicalProcess
      name: RNA phosphodiester bond hydrolysis, exonucleolytic
    - id: GO:0043631
      label: BiologicalProcess
      name: RNA polyadenylation
    - id: NCBITaxon:10299
      label: OrganismTaxon
      name: Human alphaherpesvirus 1 strain 17
    - id: MESH:D016849
      label: Disease
      name: Keratitis, Herpetic
  reference: https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1090/ https://en.wikipedia.org/wiki/Vidarabine#Mode_of_action https://go.drugbank.com/drugs/DB00194
  comments: This disease is denoted as Herpes simplex keratitis in the original file as per DrugCentral. The drug needs to be converted to Vidarabine Phosphate first (monophosphate --> diphosphate --> triphosphate) to become active and exert its role as inhibitor (https://pubchem.ncbi.nlm.nih.gov/compound/21704#section=Mechanism-of-Action).
- directed: true
  graph:
    disease: Keratitis, Dendritic
    disease_mesh: MESH:D007635
    drug: vidarabine
    drug_mesh: MESH:D014740
    drugbank: DB:DB00194
  links:
    - key: produces
      source: MESH:D014740
      target: MESH:D001084
    - key: decreases activity of
      source: MESH:D001084
      target: UniProt:P04293
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0039686
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0090503
    - key: positively regulates
      source: UniProt:P04293
      target: GO:0043631
    - key: in taxon
      source: GO:0043631
      target: NCBITaxon:10299
    - key: in taxon
      source: GO:0039686
      target: NCBITaxon:10299
    - key: in taxon
      source: GO:0090503
      target: NCBITaxon:10299
    - key: causes
      source: NCBITaxon:10299
      target: MESH:D007635
  multigraph: true
  nodes:
    - id: MESH:D014740
      label: Drug
      name: vidarabine
    - id: MESH:D001084
      label: ChemicalSubstance
      name: Vidarabine Phosphate
    - id: UniProt:P04293
      label: Protein
      name: DNA polymerase catalytic subunit
    - id: GO:0039686
      label: BiologicalProcess
      name: bidirectional double-stranded viral DNA replication
    - id: GO:0090503
      label: BiologicalProcess
      name: RNA phosphodiester bond hydrolysis, exonucleolytic
    - id: GO:0043631
      label: BiologicalProcess
      name: RNA polyadenylation
    - id: NCBITaxon:10299
      label: OrganismTaxon
      name: Human alphaherpesvirus 1 strain 17
    - id: MESH:D007635
      label: Disease
      name: Keratitis, Dendritic
  reference: https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1090/ https://en.wikipedia.org/wiki/Vidarabine#Mode_of_action https://go.drugbank.com/drugs/DB00194
  comments: This disease is denoted as Herpes simplex dendritic keratitis in the original file as per DrugCentral. The drug needs to be converted to Vidarabine Phosphate first (monophosphate --> diphosphate --> triphosphate) to become active and exert its role as inhibitor (https://pubchem.ncbi.nlm.nih.gov/compound/21704#section=Mechanism-of-Action).
- directed: true
  graph:
    disease: Liver Neoplasms
    disease_mesh: MESH:D008113
    drug: floxuridine
    drug_mesh: MESH:D005467
    drugbank: DB:DB00322
  links:
    - key: produces
      source: MESH:D005467
      target: CHEBI:46345
    - key: decreases activity of
      source: CHEBI:46345
      target: UniProt:P04818
    - key: positively regulates
      source: UniProt:P04818
      target: GO:0006235
    - key: positively regulates
      source: UniProt:P04818
      target: GO:0006231
    - key: positively correlated with
      source: GO:0006231
      target: GO:0006260
    - key: positively correlated with
      source: GO:0006235
      target: GO:0006260
    - key: precedes
      source: GO:0006260
      target: HP:0031377
    - key: positively correlated with
      source: HP:0031377
      target: MESH:D008113
  multigraph: true
  nodes:
    - id: MESH:D005467
      label: Drug
      name: floxuridine
    - id: CHEBI:46345
      label: ChemicalSubstance
      name: 5-fluorouracil
    - id: UniProt:P04818
      label: Protein
      name: Thymidylate synthase
    - id: GO:0006235
      label: BiologicalProcess
      name: dTTP biosynthetic process
    - id: GO:0006231
      label: BiologicalProcess
      name: dTMP biosynthetic process
    - id: GO:0006260
      label: BiologicalProcess
      name: DNA replication
    - id: HP:0031377
      label: PhenotypicFeature
      name: Abnormal cell proliferation
    - id: MESH:D008113
      label: Disease
      name: Liver Neoplasms
  reference: https://go.drugbank.com/drugs/DB00322#mechanism-of-action https://en.wikipedia.org/wiki/Floxuridine#Mechanism_of_action https://en.wikipedia.org/wiki/Fluorouracil#Mechanism_of_action
  comments: This disease is denoted as Malignant neoplasm of liver in the original file as per DrugCentral.
- directed: true
  graph:
    disease: Non-small cell lung cancer
    disease_mesh: MESH:D002289
    drug: vinorelbine
    drug_mesh: MESH:C030852
    drugbank: DB:DB00361
  links:
    - key: decreases activity of
      source: MESH:C030852
      target: InterPro:IPR000217
    - key: positively regulates
      source: InterPro:IPR000217
      target: GO:0000086
    - key: positively correlated with
      source: GO:0000086
      target: GO:0051301
    - key: positively correlated with
      source: GO:0051301
      target: HP:0031377
    - key: positively correlated with
      source: HP:0031377
      target: MESH:D002289
  multigraph: true
  nodes:
    - id: MESH:C030852
      label: Drug
      name: vinorelbine
    - id: InterPro:IPR000217
      label: GeneFamily
      name: Tubulin
    - id: GO:0000086
      label: BiologicalProcess
      name: G2/M transition of mitotic cell cycle
    - id: GO:0051301
      label: BiologicalProcess
      name: cell division
    - id: HP:0031377
      label: PhenotypicFeature
      name: Abnormal cell proliferation
    - id: MESH:D002289
      label: Disease
      name: Non-small cell lung cancer
  reference: https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL553025/ https://go.drugbank.com/drugs/DB00361#mechanism-of-action https://en.wikipedia.org/wiki/Vinorelbine#Pharmacology
  comments: The MESH disease term (MESH:D002289) is known as Carcinoma, Non-Small-Cell Lung on the MESH website.
- directed: true
  graph:
    disease: Itching of skin
    disease_mesh: MESH:D011537
    drug: phenol
    drug_mesh: MESH:D019800
    drugbank: DB:DB03255
  links:
    - key: subclass of
      source: MESH:D019800
      target: MESH:D000982
    - key: subclass of
      source: MESH:D019800
      target: MESH:D000890
    - key: ameliorates
      source: MESH:D000982
      target: MESH:D011537
    - key: ameliorates
      source: MESH:D000890
      target: MESH:D011537
  multigraph: true
  nodes:
    - id: MESH:D019800
      label: Drug
      name: phenol
    - id: MESH:D000982
      label: ChemicalSubstance
      name: Antipruritics
    - id: MESH:D000890
      label: ChemicalSubstance
      name: Anti-Infective Agents
    - id: MESH:D011537
      label: Disease
      name: Itching of skin
  reference: https://go.drugbank.com/drugs/DB03255#indication https://www.genome.jp/dbget-bin/www_bget?drug:D00033 https://pubchem.ncbi.nlm.nih.gov/compound/996#section=Pharmacology
  comments: Term MESH:D011537 is also known as pruritus.

